Cypridina was first characterized by Dr Osamu and Akemi Shimomura from “Umi Hotaru” Japanese Sea Fireflies in 1966. These are bottom dwelling ostracods that emit a light stream into water when disturbed presumably to deter predation. Cypridina Luciferase was first cloned by Eric Thompson, and S. Nagata under Fred Tsuji in Japan 1989. Cypridina is a 555 amino acid, 62.171 KDa protein that oxidizes the luciferin to produce blue light at 462 nm Em Max. The advantage of using the Cypridna system: it does not cross react with Coelenterazine or Firefly d-Luciferin so it may be used in multiplex assays, brighter then Firefly LuciferasennThe advantages of lyophilized luciferins are:nnpre-aliquoted in small amounts, fresh substrate for every set of experimentsnlong shelf-life (packed under Argon)nfaster to dissolve due to its fine crystal structurenconsistent quality between aliquotes
產品描述
Lyophilized Cypridina Luciferin 99% pure. Identical to Vargula Luciferin. 10 mg, (2 x 5mgs)
產品形式
305-10 Cypridina產品形式查看提供的datasheet
保存建議
室溫
其他
NanoLight&Technologies公司是Prolume Ltd公司的分公司，公司由Prolume Ltd公司創始人Dr. Bruce Bryan等共同創立。Nanolight&Technology公司生產和銷售天然，發光海洋生物蛋白或海洋生物發光物質。NanoLight 專注于為藥廠、農用化學品及科研試劑生產企業提供高性價比的檢測試劑。nnNanoLight公司產品應用包括高通量藥物開發、基因組功能研究、腫瘤成像、放射性同位素替代品以及分子診斷。NanoLight產品的一個廣泛的應用是通過NanoLight 報告系統研究活細胞中基因和分子功能，通過這種方法為藥廠研究藥物活性提供了一種創新性的解決方法。nnNanoLight產品的另外一個應用是為廣大科研人員減少使用放射性試劑，用NanoLight公司的基于發光報告系統作為替代品。由于以上應用，NanoLight產品得到了科研客戶的廣泛信賴。
